R3 Stem Cell Research Publishes Review on Stem Cell Therapy for Scleroderma

R3 Stem Cell Research has published a peer-reviewed review article in *Stem Cell Reviews and Reports*, examining mesenchymal stem cell (MSC) therapy for systemic sclerosis (scleroderma). The review highlights MSCs' potential to address immune, vascular, and fibrotic processes, with early studies showing feasibility, acceptable short-term safety, and encouraging signals in outcomes like skin thickening. This research could inform future therapeutic strategies for the condition.